Xiao Cheng

2.2k total citations · 2 hit papers
41 papers, 1.7k citations indexed

About

Xiao Cheng is a scholar working on Molecular Biology, Biomedical Engineering and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiao Cheng has authored 41 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 13 papers in Biomedical Engineering and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiao Cheng's work include Extracellular vesicles in disease (10 papers), Nanoplatforms for cancer theranostics (8 papers) and RNA Interference and Gene Delivery (5 papers). Xiao Cheng is often cited by papers focused on Extracellular vesicles in disease (10 papers), Nanoplatforms for cancer theranostics (8 papers) and RNA Interference and Gene Delivery (5 papers). Xiao Cheng collaborates with scholars based in China, United States and France. Xiao Cheng's co-authors include Chirag B. Godiya, Xiaolin Lü, Dawei Li, Zhan Chen, Ke Cheng, Shiqi Hu, Ning Gu, Fang Yang, Yang Liu and Jing Li and has published in prestigious journals such as Science, Advanced Materials and Nature Communications.

In The Last Decade

Xiao Cheng

38 papers receiving 1.7k citations

Hit Papers

Carboxymethyl cellulose/p... 2018 2026 2020 2023 2018 2022 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiao Cheng China 20 644 536 328 261 244 41 1.7k
Yue Chen China 18 496 0.8× 680 1.3× 138 0.4× 409 1.6× 125 0.5× 63 1.8k
Xinze Ran China 22 579 0.9× 323 0.6× 375 1.1× 192 0.7× 52 0.2× 71 1.9k
Xi Li China 21 582 0.9× 480 0.9× 117 0.4× 280 1.1× 47 0.2× 65 1.5k
Tian Xie China 13 631 1.0× 1.1k 2.0× 403 1.2× 601 2.3× 58 0.2× 29 1.9k
Karen Alt Australia 26 627 1.0× 854 1.6× 777 2.4× 614 2.4× 88 0.4× 56 2.7k
Xueqin Zhao China 20 353 0.5× 463 0.9× 229 0.7× 249 1.0× 136 0.6× 96 1.6k
Yonghyun Choi South Korea 23 408 0.6× 671 1.3× 313 1.0× 359 1.4× 60 0.2× 73 1.5k
Jeong‐Ho Yun South Korea 31 830 1.3× 822 1.5× 174 0.5× 286 1.1× 57 0.2× 103 3.2k
Chiaki Yoshikawa Japan 25 358 0.6× 434 0.8× 395 1.2× 177 0.7× 38 0.2× 67 1.7k
Hong Wu China 26 608 0.9× 1.0k 1.9× 893 2.7× 403 1.5× 41 0.2× 61 2.1k

Countries citing papers authored by Xiao Cheng

Since Specialization
Citations

This map shows the geographic impact of Xiao Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao Cheng more than expected).

Fields of papers citing papers by Xiao Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiao Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao Cheng. The network helps show where Xiao Cheng may publish in the future.

Co-authorship network of co-authors of Xiao Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Xiao Cheng. A scholar is included among the top collaborators of Xiao Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiao Cheng. Xiao Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Shuo, et al.. (2026). Single intramuscular injection of self-amplifying RNA of Nppa to treat myocardial infarction. Science. 391(6789). edau9394–edau9394.
3.
Lu, Qianglan, Fei Zeng, Zhiyong Liu, et al.. (2025). Targeting Senescent Alveolar Type 2 Cells with a Gene-Editable FePt Dual-Atom Catalyst for Mitigating Idiopathic Pulmonary Fibrosis. ACS Nano. 19(25). 23162–23176.
4.
You, Yang, Mengrui Liu, Na Yan, et al.. (2025). Smart Materials and Devices for Enhanced Delivery of Extracellular Vesicles. Advanced Materials. 37(34). e2501081–e2501081. 2 indexed citations
5.
Koo, Doyeon, Xiao Cheng, Sevana Baghdasarian, et al.. (2024). Optimizing cell therapy by sorting cells with high extracellular vesicle secretion. Nature Communications. 15(1). 4870–4870. 18 indexed citations
6.
Zhang, Yuting, Yupeng Wang, Guoxing You, et al.. (2023). FTO-targeted siRNA delivery by MSC-derived exosomes synergistically alleviates dopaminergic neuronal death in Parkinson's disease via m6A-dependent regulation of ATM mRNA. Journal of Translational Medicine. 21(1). 652–652. 47 indexed citations
7.
Yu, Zhiyong, Yuting Zhang, Yupeng Wang, et al.. (2023). FTO alleviates cerebral ischemia/reperfusion-induced neuroinflammation by decreasing cGAS mRNA stability in an m6A-dependent manner. Cellular Signalling. 109. 110751–110751. 44 indexed citations
8.
Fan, Shuangshuang, Xiao Cheng, Kai Qiao, Shuo Liu, & Wen Xu. (2022). Optimization design and experimental validation of a vortex-based suction cup for a climbing AUV. Ocean Engineering. 257. 111602–111602. 4 indexed citations
9.
Popowski, Kristen D., Adele Moatti, Halle Lutz, et al.. (2022). Inhalable dry powder mRNA vaccines based on extracellular vesicles. Matter. 5(9). 2960–2974. 163 indexed citations breakdown →
10.
Li, Lin, Long Bai, Huan Lin, et al.. (2021). Multiomics analysis of tumor mutational burden across cancer types. Computational and Structural Biotechnology Journal. 19. 5637–5646. 19 indexed citations
11.
Zhu, Yong, Rumeng Zhang, Ying Zhang, et al.. (2021). NUDT21 Promotes Tumor Growth and Metastasis Through Modulating SGPP2 in Human Gastric Cancer. Frontiers in Oncology. 11. 10 indexed citations
12.
Cheng, Xiao, Lin Li, Rumeng Zhang, et al.. (2021). A Novel Small Molecular Antibody, HER2-Nanobody, Inhibits Tumor Proliferation in HER2-Positive Breast Cancer Cells In Vitro and In Vivo. Frontiers in Oncology. 11. 669393–669393. 14 indexed citations
13.
He, Xiaobo, et al.. (2021). Clinical Symptom Differences Between Mild and Severe COVID-19 Patients in China: A Meta-Analysis. Frontiers in Public Health. 8. 561264–561264. 61 indexed citations
14.
Cheng, Xiao, et al.. (2021). A 4-gene-based hypoxia signature is associated with tumor immune microenvironment and predicts the prognosis of pancreatic cancer patients. World Journal of Surgical Oncology. 19(1). 123–123. 24 indexed citations
15.
Li, Mingxi, Jing Li, Jinpeng Chen, et al.. (2020). Platelet Membrane Biomimetic Magnetic Nanocarriers for Targeted Delivery and in Situ Generation of Nitric Oxide in Early Ischemic Stroke. ACS Nano. 14(2). 2024–2035. 208 indexed citations
16.
Xie, Mengjie, Sichen Zhang, Dashuai Zhu, et al.. (2020). A trifunctional contraceptive gel enhances the safety and quality of sexual intercourse. Bioactive Materials. 6(6). 1777–1788. 4 indexed citations
17.
Guo, Zhaoming, Xiao Cheng, Dong Wang, et al.. (2020). Versatile biomimetic cantharidin-tellurium nanoparticles enhance photothermal therapy by inhibiting the heat shock response for combined tumor therapy. Acta Biomaterialia. 110. 208–220. 38 indexed citations
18.
Bai, Jie, et al.. (2018). Differentiating skull base chordomas and invasive pituitary adenomas with conventional MRI. Acta Radiologica. 59(11). 1358–1364. 6 indexed citations
19.
Zhang, Chao, Xiao Cheng, Jie Sheng, et al.. (2017). Fluorescence guided photothermal/photodynamic ablation of tumours using pH-responsive chlorin e6-conjugated gold nanorods. Colloids and Surfaces B Biointerfaces. 160. 345–354. 66 indexed citations
20.
Zhang, Jing, Xi Guang Chen, Gang Sun, Lu Huang, & Xiao Cheng. (2010). Effect of molecular weight on the oleoyl-chitosan nanoparticles as carriers for doxorubicin. Colloids and Surfaces B Biointerfaces. 77(2). 125–130. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026